These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 9823337)

  • 1. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
    Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK
    Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
    Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
    J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.
    Singh AV; Franke AA; Blackburn GL; Zhou JR
    Cancer Res; 2006 Feb; 66(3):1851-8. PubMed ID: 16452247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer.
    Su SJ; Yeh TM; Lei HY; Chow NH
    Clin Cancer Res; 2000 Jan; 6(1):230-6. PubMed ID: 10656454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity.
    Su SJ; Chow NH; Kung ML; Hung TC; Chang KL
    Nutr Cancer; 2003; 45(1):113-23. PubMed ID: 12791511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary soy isoflavones increase metastasis to lungs in an experimental model of breast cancer with bone micro-tumors.
    Yang X; Belosay A; Hartman JA; Song H; Zhang Y; Wang W; Doerge DR; Helferich WG
    Clin Exp Metastasis; 2015 Apr; 32(4):323-33. PubMed ID: 25749878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice.
    Zhou JR; Yu L; Mai Z; Blackburn GL
    Int J Cancer; 2004 Jan; 108(1):8-14. PubMed ID: 14618609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.
    Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E
    Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells.
    Pagliacci MC; Smacchia M; Migliorati G; Grignani F; Riccardi C; Nicoletti I
    Eur J Cancer; 1994; 30A(11):1675-82. PubMed ID: 7833143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soy processing influences growth of estrogen-dependent breast cancer tumors.
    Allred CD; Allred KF; Ju YH; Goeppinger TS; Doerge DR; Helferich WG
    Carcinogenesis; 2004 Sep; 25(9):1649-57. PubMed ID: 15131010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones.
    Bielecki A; Roberts J; Mehta R; Raju J
    Nutr Cancer; 2011; 63(1):139-50. PubMed ID: 21161820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer.
    Mizunuma H; Kanazawa K; Ogura S; Otsuka S; Nagai H
    Oncology; 2002; 62(1):78-84. PubMed ID: 11810047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soy isoflavones and cancer prevention.
    Sarkar FH; Li Y
    Cancer Invest; 2003; 21(5):744-57. PubMed ID: 14628433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive effects of soy protein and purified soy isoflavones on DMBA-induced mammary tumors in female Sprague-Dawley rats.
    Constantinou AI; Lantvit D; Hawthorne M; Xu X; van Breemen RB; Pezzuto JM
    Nutr Cancer; 2001; 41(1-2):75-81. PubMed ID: 12094632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice.
    Santell RC; Kieu N; Helferich WG
    J Nutr; 2000 Jul; 130(7):1665-9. PubMed ID: 10867033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different mechanisms of soy isoflavones in cell cycle regulation and inhibition of invasion.
    Kim MH; Gutierrez AM; Goldfarb RH
    Anticancer Res; 2002; 22(6C):3811-7. PubMed ID: 12552999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
    Hedlund TE; Johannes WU; Miller GJ
    Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo.
    Raffoul JJ; Banerjee S; Singh-Gupta V; Knoll ZE; Fite A; Zhang H; Abrams J; Sarkar FH; Hillman GG
    Cancer Res; 2007 Mar; 67(5):2141-9. PubMed ID: 17332344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary studies on induction of apoptosis by genistein on HepG2 cell line.
    Chodon D; Ramamurty N; Sakthisekaran D
    Toxicol In Vitro; 2007 Aug; 21(5):887-91. PubMed ID: 17391909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.